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Introduction: The present study examines how the trends in the prevalence of chronic bron-
chitis during the last three decades associate with changes in smoking habits during the same
period.
Methods: Altogether 47 896 subjects aged 25e74 years were examined in six independent
cross-sectional population surveys repeated every five years between 1982 and 2007 in
Finland. The presence of chronic bronchitis, smoking habits and other risk factors were
measured by standard questionnaires.
Results: During the study, the prevalence of chronic bronchitis was significantly higher in men
than in women. In men aged 25e64 years, the prevalence of chronic bronchitis decreased from
19% in 1982 to 13% in 2007 (p for trend <0.001). The corresponding decrease in women aged 25
e64 years was from 13% to 11% (p for trend 0.009). In men aged 65e74 years, the prevalence of
chronic bronchitis decreased from 24% to 19% (p for trend 0.032). Simultaneously, male smok-
ing decreased and smoking in middle-aged women increased. However, adjusting for the
changes in smoking habits did not change the declining trends in the prevalence of chronic
bronchitis. The significant declining trend in chronic bronchitis was seen separately in male
current smokers and in male and female never smokers aged 45e74 years and the declining
trend was the greatest in male current smokers. In general, female smokers with chronic bron-
chitis had smoked less than their male counterparts.of Pulmonary Diseases, Kuopio University Hospital, Po Box 100, FI-70029 Kuopio, Finland. Tel.: þ358
uh.fi (M.K. Pelkonen).
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1634 M.K. Pelkonen et al.Conclusion: There was a declining trend in the prevalence of chronic bronchitis which was
probably explained by both a decrease in smoking and by other factors.
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Chronic bronchitis is characterized by chronic mucus
secretion from airways and smoking plays an important role
in its pathogenesis [1]. Exposures to occupational airborne
particles as well as ageing may also contribute to chronic
bronchitis [2,3]. Chronic bronchitis, in turn, has been
associated with an accelerated decline in FEV1 [4,5], with
lower life quality [6], increased medical costs [7] and finally
with increased respiratory, cardiovascular and all cause
mortality [4,8e11].
According to the earlier studies from the United States
(the Tecumseh study) and Scotland (the Renfrew and
Paisley survey) the prevalence of chronic phlegm produc-
tion (most mornings for 3 months/year) was in
1960s1970s about 27e28% in general male population
aged 40e64 years [9]. In elderly smoking rural Finnish men
and women (with mean age 59 and 56, respectively), the
prevalence of chronic phlegm production was 41% and 21%,
respectively in 1971 [12]. In 1972e77 the prevalence of
chronic bronchitis was 22% and 12%, respectively in general
Finnish male and female population aged 30e64 years [13].
In the 1980s in Italy altogether 18% and 5% of men and
women aged 20e64 years, respectively, reported to have
chronic phlegm production and the prevalence increased
with age and smoking [3]. In 1995, the prevalence of
chronic productive cough in northern Finland was 12% in
men (10% in women) aged 20e69 years (and 19% in men
aged 60e69 years) [14]. Since the beginning of 1970s many
tobacco control initiatives have been carried out in Finland
and male smoking has declined remarkably since 1972 [15].
On the other hand, Finnish women, like women in many
western countries, increased their smoking in the 1970s
[15e17]. The present study examines the trends in the
prevalence of chronic bronchitis between 1982 and 2007
and their relation to changes in smoking habits in Finland.
Methods
Subjects
Cross-sectional risk factor surveys were conducted every
fifth year in Finland by the National Public Health Institute
since 1972 [15,18]. Independent population samples were
studied in five areas: in the provinces of North Karelia and
Kuopio since 1972, in south-western Finland since 1982, in
cities of Helsinki and Vantaa since 1992, in Oulu since 1997
and in Lapland since 2002. The study subjects were drawn
from the population register by random sampling and the
target population was 25e64 year old subjects. The study
samples were stratified according to sex and 10-year age
group so that at least 250 people (at least 200 in 2007)
were included in each subgroup. The sampling methodwas modified to comply with the protocol of the World
Health Organisation MONICA (Multinational Monitoring of
trends and determinants in Cardiovascular disease) proj-
ect [19] and since 2002 the later recommendations of the
European Health Risk Monitoring project (EHRM) [20].
Actually, the National FINRISK Studies (1982e1992) were
part of the WHO MONICA project and since 1982 also part
of the WHO CINDI (Countrywide Integration Non-
communicable Diseases Intervention) program [15].
There was also a sample of subjects aged 65e74 years in
the province of North Karelia and Helsinki since 1997 and
in Lapland since 2002.
The present study includes six surveys of these National
FINRISK Studies, i.e. surveys carried out between 1982 and
2007 (n Z 47 896) (Table 1). In the present study, both
those smokers who had no complete data on smoking and
those smokers who had quit smoking less than a month ago
were excluded from analyses (altogether nZ 903 between
1982 and 2007). Those subjects who had no data on the
symptoms of chronic bronchitis (n Z 1540) and subjects
who reported of having asthma diagnosed by a doctor
(n Z 1727) (Table 1) were also excluded.Measurement of chronic bronchitis, smoking status
and other variables
Chronic bronchitis was defined in subjects without a history
of asthma by a positive response to the same standard
question ‘Do you bring up phlegm on most days or nights for
at least as much as three months each year’ [4,9,21] in a
self administered questionnaire. Smoking, marital status,
education and occupation were also asked with stand-
ardised questions. Smoking status was classified into the
three categories: never-, ex- and current-smokers (Table
1). Smokers had smoked regularly at least one year (ciga-
rettes, cigars or pipe) and had smoked during the preceding
month. Ex-smokers had stopped smoking at least one month
before the survey. The pack-year was calculated by multi-
plying the years of smoking by the daily number of smoked
cigarettes and then dividing the product by 20.
Occupation was classified into seven categories: agri-
culture and dairy farming, factory, mine and construction
work, the unemployed, students, housewives, pensioners
and office work (or suchlike work, e.g. service activity).
The level of education was classified into four categories:
an elementary school, a vocational school, an upper sec-
ondary school/college and an academic degree. Marital
status was classified into four categories: married/cohabi-
tation without marriage, unmarried, divorced and wid-
owed. The area of residence was classified into four
categories: North Karelia and Kuopio, south-western
Finland, Lapland and Oulu, and the capital area (cities of
Helsinki and Vantaa).
Table 1 Description of the study population by the year of examination, smoking status, the presence of chronic bronchitis
and self-reported asthma.
The year of examination
n 1982 1987 1992 1997 2002 2007
Invited 11 395 7932 7927 11 500 13 498 12 000
Examined (men/women) 9347
(4615/4732)
6479
(3109/3370)
6051
(2849/3202)
8446
(4253/4193)
9580
(4482/5098)
7993
(3740/4253)
Non-responders (men/women) 2048
(1212/836)
1453
(853/600)
1876
(1116/760)
3054
(1747/1307)
3918
(2267/1651)
4007
(2260/1747)
Smoking status
Never smokers 3962 2804 2596 3752 4294 3634
Ex-smokers 2289 1675 1622 2317 2490 2425
Current smokers 2791 1805 1811 2117 2725 1855
Excludeda 305 195 22 260 71 79
Chronic bronchitis 1284 785 855 1085 1175 879
A history of asthma (excluded) 144 145 178 385 459 416
Without data of chronic
bronchitis/asthma (excluded)
288 529 6 208 238 271
a Excluded were subjects without data on smoking or when last smoked and ex-smokers who had quit smoking less than one month ago.
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The area-adjusted age-specific prevalence rates of chronic
bronchitis (nZ 21 099 and n Z 22 598 in men and women,
respectively) were calculated from the results of the lo-
gistic regression models, which were fitted for each age
group and gender separately using the year of examination
and the area as independent categorical variables, using
the following formula:
Adjusted prevalenceZEXPðConstantþ Bi_YearÞ=1
þ EXPðConstantþ Bi_YearÞ:
Changes in smoking habits during the study in five ten-
year age groups were examined using c2 test.
The age-specific trends in chronic bronchitis and the
possible intermediate role of smoking and other covariates
were studied by logistic regression analyses. For each
group three models were fitted. The first model included
the following independent variables: the year of exami-
nation as a continuous variable and area as a categorical
variable; the second model included additionally smoking
status as a categorical variable; the third model included
additionally occupation, education and marital status as
categorical variables. The trend in the prevalence of
chronic bronchitis was further studied by analysing the
smoking groups separately by similar modelling (1st and
3rd models). In current smokers, analyses were addition-
ally adjusted for pack-years. Covariance analysis
(n Z 11 067) was used to examine the trends in mean
pack-years in smokers by ten-year age groups. Covariance
analysis was also applied to study (age and the year of
examination) adjusted mean pack-years by the presence
of chronic bronchitis.
Statistical analyses were performed by SPSS 19.0 for
Windows.
The study was approved in 2001 by the ethics committee
at the National Institute for Health and Welfare in Helsinki.Results
Between 1982 and 2007 chronic bronchitis was more prev-
alent in men than in women in all age groups (p < 0.001,
except in the oldest age group pZ 0.021) (Fig. 1). In men,
the prevalence of chronic bronchitis declined during the
follow-up significantly from 21% (95% CI 16e26%) to 15%
(95% CI 11e18%), from 28% (95% CI 23e34%) to 14% (95% CI
11e18%) and from 24% (95% CI 19e30%) to 19% (95% CI
15e24%), respectively in subjects aged 45e54, 55e64 and
65e74 years. In women, there was a significantly
decreasing trend in the youngest age group (from 10% (95%
CI 7e14%) to 7% (95% CI 5e10%)) and in subjects aged 55e64
years (from 16% (95% CI 12e20%) to 11 (95% CI 8e14%)).
Altogether the prevalence of chronic bronchitis in men
aged 24e64 years decreased from 19% (95% CI 17e21%) to
13% (95% CI 12e15%). The corresponding decrease in
women aged 24e64 years was from 13% (95% CI 11e15%) to
11% (95% CI 9e12%).
Between 1982 and 2007 the percentage of current
smokers declined and the percentage of never smokers
increased significantly (p for trend <0.001) in all other male
age groups, except in the oldest (Fig. 2). In women, the
percentage of never smokers increased significantly only in
subjects aged 25e34 years and the percentage of never
smokers decreased clearly in women aged 35e44, 45e54
and 55e64 years of age (p for trend<0.001) (Fig. 2). During
the follow-up (Table E1 on the online repository), there was
a significant decreasing trend in pack-years in male current
smokers aged 25e34, 35e44 and 45e55 years (p for trend
<0.001, 0.010 and 0.001, respectively) and in female cur-
rent smokers aged 35e44 years (p for trend 0.041). In fe-
male current smokers aged 45e54 and 55e64 years, there
was a significant (p < 0.001) increasing trend in pack-years
during the follow-up (Table E1).
In men aged 45 years and in women aged 55 years
(Table 2) there was a significant decreasing trend in the
area-adjusted prevalence of chronic bronchitis which did
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Figure 1 The adjusted prevalence of chronic bronchitis by 10-year age group and the year of examination between 1982 and 2007
in men and women. The 95% confidence intervals are omitted because of clarity. Adjusted for the area of residence. p for the trend
in parenthesis.
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Figure 2 The percentages of current and never smokers by the age group and the year of examination between 1982 and 2007 in
men and women. The p-values for the trend were calculated by Chi-square-test using the smoking status as a three-category
variable (never-, ex- and current-smokers). The number of subjects in each age group the same as in Fig. 1. The percentages of
ex-smokers are omitted from Fig. 2 because of clarity.
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Table 2 Multivariate adjusted odds ratios (OR) for the trend in chronic bronchitis during 1982e2007 by ten-year age groups.
n OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value
Model 1a Model 2b Model 3c
Men
Age group
25e34 4320 0.995 (0.983e1.007) 0.402 0.998 (0.986e1.011) 0.801 1.002 (0.989e1.015) 0.773
35e44 4787 0.997 (0.986e1.007) 0.556 1.000 (0.989e1.011) 0.993 1.002 (0.990e1.013) 0.795
45e54 4863 0.983 (0.974e0.993) 0.001 0.983 (0.973e0.993) 0.001 0.984 (0.974e0.995) 0.005
55e64 4894 0.969 (0.960e0.979) <0.001 0.975 (0.965e0.984) <0.001 0.974 (0.964e0.984) <0.001
65e74 1862 0.967 (0.938e0.997) 0.031 0.970 (0.940e1.000) 0.054 0.972 (0.941e1.003) 0.077
Women
Age group
25e34 4958 0.987 (0.974e1.000) 0.046 0.989 (0.976e1.002) 0.105 0.993 (0.979e1.008) 0.355
35e44 5231 1.001 (0.990e1.013) 0.823 1.000 (0.989e1.012) 0.962 1.005 (0.992e1.018) 0.443
45e54 5306 0.993 (0.982e1.003) 0.181 0.990 (0.979e1.001) 0.070 0.998 (0.986e1.010) 0.724
55e64 5144 0.988 (0.978e0.998) 0.018 0.988 (0.977e0.998) 0.019 0.987 (0.976e0.998) 0.025
65e74 1524 0.961 (0.926e0.998) 0.040 0.958 (0.923e0.995) 0.027 0.957 (0.920e0.995) 0.027
a From a logistic regression model with the following variables: the year of examination and the area of residence.
b From a logistic regression model with the following variables: the year of examination, smoking status and the area of residence.
c From a logistic regression model with the following variables: the year of examination, smoking status, occupation, education,
marital status and the area of residence.
25-year trends in chronic bronchitis 1637not change significantly after adjusting for smoking habits.
The inclusion of the other covariates (occupation, educa-
tion, marital status) into the model did not have any effect
on the results. The decreasing trend was further studied in
the subjects aged 45e74 years by dividing subjects into
current smokers, ex-smokers and never smokers (Table 3).
The decreasing trend in the prevalence of chronic bron-
chitis was seen in all smoking categories in men (Table 3,
Model 1). The inclusion of the other covariates into the
model did not change the results in male current and never
smokers (Table 3, Model 3). The trend remained significant
in male current smokers also after additional adjusting for
pack-years (odds ratio (OR) Z 0.972 (0.961e0.983),
p < 0.001) (not shown in Tables). In women, the significant
decreasing trend in the prevalence of chronic bronchitis
was seen separately only in never smokers (Table 3).Table 3 Multivariate adjusted odds ratiosa (OR) for the trend
subjects aged 45 to 74.
Smoking status n OR (95% CI)
Model 1a
Men
All 11 619 0.978 (0.972e0.985)
Current smokers 3471 0.971 (0.961e0.981)
Ex-smokers 4756 0.987 (0.975e0.998)
Never smokers 3392 0.979 (0.965e0.994)
Women
All 11 974 0.988 (0.981e0.995)
Current smokers 1849 0.994 (0.979e1.009)
Ex-smokers 2109 0.986 (0.967e1.005)
Never smokers 8016 0.987 (0.978e0.995)
a From a logistic regression model with the following variables: the
b From a logistic regression model with the following variables: the
status and the area of residence. When all smoking groups are includGenerally female smokers with chronic bronchitis had
smoked less than their male counterparts (on average 16.9
(95% CI 16.0e17.8) and 24.2 (95% CI 23.6e24.8) pack-years,
respectively, at the age of 43) (Fig. 3). The interaction
between gender and chronic bronchitis was significant
(p Z 0.012) pointing out that the difference in pack-years
was less between female smokers with and without
chronic bronchitis than in corresponding male smokers.
Discussion
In the present study, there was a declining trend in the
prevalence of chronic bronchitis during the last three de-
cades. The adjusted OR for the prevalence of chronic
bronchitis in 2007 compared to that in 1982 in subjects aged
45e74 years was in men 0.59 (Z0.97925 in which 0.979 isin chronic bronchitis during 1982e2007 by smoking groups in
p-Value OR (95% CI) p-Value
Model 3b
<0.001 0.979 (0.972e0.986) <0.001
<0.001 0.970 (0.960e0.980) <0.001
0.025 0.990 (0.978e1.003) 0.127
0.005 0.976 (0.961e0.992) 0.003
0.001 0.992 (0.984e1.000) 0.039
0.441 0.997 (0.981e1.014) 0.747
0.154 0.990 (0.970e1.011) 0.344
0.003 0.990 (0.980e1.000) 0.050
year of examination, age group and the area of residence.
year of examination, age group, occupation, education, marital
ed the analysis was adjusted for smoking status also.
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Figure 3 Adjusted average pack-years (95% confidence intervals) at the age of 43 in current smokers by gender and the presence
of chronic bronchitis during 1982e2007. From covariance analysis, adjusted for age and the year of examination.
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the follow-up) and 0.82 (Z0.99225) in women. During the
follow-up smoking decreased in men and increased in
middle-aged women.
Consistently, in a 9-year European follow-up study the
prevalence of chronic bronchitis at the end was similar or
slightly lower than at the baseline in 1991e93 [22]. The
decreasing trends in the prevalence of chronic bronchitis
may be mostly explained by the decreasing trends in
smoking [23,24]. E.g. in Europe, there has been a decline
in smoking among men in all education levels and in more
educated women between 1985 and 2000 [23]. In our
study, however, only some part of the decreasing trend in
chronic bronchitis in men could be explained by changes in
smoking habits. In addition, among women, whose smok-
ing rates increased during the study, there was also a
decreasing trend in chronic bronchitis. Furthermore, the
significant decreasing trend was seen separately in never
smokers too. However, in our results there can be left
some residual confounding of smoking because we used
cross-sectional survey data and smoking habits were asked
only once. In addition, we could not take into account
that exposure to environmental tobacco smoke (ETS) has
decreased markedly in Finland from the 1980s’ because of
legislative smoking restrictions [25], reinforced later with
smoke-free workplace legislation [26]. The ETS exposure
at work has been more common in smokers than in non-
smokers, but it has decreased among smokers too and
slightly also at home [25]. In our study, male smoking
decreased during the follow-up likely leading to further
decreasing ETS at home. Thus, the decreasing exposure to
ETS may explain at least partly the decreasing trend in
chronic bronchitis. Accordingly, it has been found earlier
that spousal smoking is associated with phlegm production
in non-smoking women [27].
The duration of abstinence among ex-smokers in the
present study was reported roughly in 1982e92. Generally,
most of ex-smokers (72 %) had quit smoking 1/2 year e 1
year before the study. Accordingly, in a previous study, a
significant decline in respiratory symptoms has been shown
already after 12 weeks of abstinence [28]. Unfortunately
few our ex-smokers reported how much they had smoked
before. Thus, we could not study thoroughly the effects of
quitting smoking.
Working in dusty occupations and air pollution has been
associated with chronic bronchitis [22,29]. However, in the
present study after controlling for smoking, occupation andother variables, the decreasing trend in chronic bronchitis
remained significant. However, our categorization of oc-
cupations was rather crude and though our analyses were
adjusted for the occupation this adjustment may not have
taken into account all advances in occupational technology
during the follow-up. On the other hand, those study sub-
jects who were middle-aged and older in the 1980s had in
their childhood and adulthood weaker health care than
subjects born in later years (Finland has had a primary
health care system based on health centres since 1972
[30]). Also housing conditions have changed, for example in
the past the use of wood as a cooking fuel and to heat the
houses was more common. Supporting these ideas, chest
infections in childhood [10] and biomass burning [31] have
been associated with chronic bronchitis. In smokers these
factors may have affected more on the development of
chronic bronchitis than in non-smokers suggested by the
stronger decline in the prevalence in male smokers.
There are some sources of bias which may exaggerate
the decline in our prevalence rates. Firstly, the participa-
tion rates decreased during the course of the study. In
general, in questionnaire studies non-responders tend to be
smokers [32] e this does not, however, bias our results,
because smoking status was taken into account in analysis.
In addition, non-responders have not reported more respi-
ratory symptoms than responders evaluated by a telephone
interview [32]. Secondly, during 1982e87 fewer study sub-
jects were excluded because of reporting having asthma
than in later years probably resulting from both a real in-
crease in asthma prevalence and increased diagnostic ac-
tivity [33]. Thus some subjects with asthma may have been
misclassified as having chronic bronchitis in the first ten
years. Generally, our prevalence rates of chronic bronchitis
for men and women aged 24e64 years were in the 1990s at
the same level as reported in another Finnish study [34].
Chronic bronchitis has been associated with a risk to
develop COPD (chronic obstructive pulmonary disease)
[4,5,8] e even in young adults [35]. In the present study,
because there were no measurements of pulmonary func-
tion, the prevalence of COPD can not be estimated. Ac-
cording to another Finnish study, half of smokers with
chronic bronchitis later developed COPD [4]. In one study,
subjects with COPD and chronic bronchitis had a greater
risk of exacerbations than subjects with COPD without
chronic bronchitis [36]. Thus, declining trends in chronic
bronchitis might lead to declining trends in COPD,
morbidity and mortality [4,8,10]. In women, increased
25-year trends in chronic bronchitis 1639susceptibility to the harmful effects of smoking has been
shown earlier [37]. In our study, female smokers with
chronic bronchitis had smoked fewer pack-years than their
male counterparts. However, there was no significant
decreasing trend in chronic bronchitis in female smokers e
may be because during the follow-up middle-aged female
smokers increased their smoking.
In conclusion, there was a declining trend in chronic
bronchitis which could not be explained only by the
changes in smoking habits. Possibly, the decrease in expo-
sure to ETS explains the trend at least partly.
Funding
Supported by the Finnish Anti-Tuberculosis Association
Foundation and the EVO Funds of the Kuopio University
Hospital.
Conflict of interest
No author has any conflict of interest.Appendix A. Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.rmed.2014.08.007.
References
[1] Sethi JM, Rochester CL. Smoking and chronic obstructive
pulmonary disease. Clin Chest Med 2000;21:67e86.
[2] Kuschner WG, Hegde S, Agrawal M. Occupational history
quality in patients with newly documented, clinician-
diagnosed chronic bronchitis. Chest 2009;135:378e83.
[3] Viegi G, Paoletti P, Prediletto R, Carrozi L, Fazzi P, Di Pede F,
Pistelli G, Giuntini C, Lebowitz MD. Prevalence of respiratory
symptoms in an unpolluted area of Northern Italy. Eur Respir J
1988;1:311e8.
[4] Pelkonen M, Notkola IL, Nissinen A, Tukiainen H, Koskela H.
Thirty-year cumulative incidence of chronic bronchitis and
COPD in relation to 30-year pulmonary function and 40-year
mortality. A follow-up in middle-aged rural men. Chest
2006;130:1129e37.
[5] Vestbo J, Prescott E, Lange P. Association of chronic mucus
hypersecretion with FEV1 decline and chronic obstructive
pulmonary disease morbidity. The Copenhagen city heart
study group. Am J Respir Crit Care Med 1996;153:1530e5.
[6] Wagena EJ, Kant I, van Amelsvoort LG, Wouters EF, van
Schayck CP, Swaen GM. Risk of depression and anxiety in
employees with chronic bronchitis: the modifying effect of
cigarette smoking. Psychosom Med 2004;66:729e34.
[7] Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic
bronchitis and COPD. A 1-year follow-up study. Chest 2003;
123:784e91.
[8] Guerra S, Sherrill DL, Venker C, Cellato CM, Halonen M,
Martinez FD. Chronic bronchitis before age 50 years predicts
incident airflow limitation and mortality risk. Thorax 2009;64:
894e900.
[9] Ebi-Kryston KL, Hawthorne VM, Rose G, Shipley MJ, Gillis CR,
Hole DJ, Carmen W, Eshleman S, Higgins MW. Breathlessness,
chronic bronchitis and reduced pulmonary function as pre-
dictors of cardiovascular disease mortality among men inEngland, Scotland and the United States. Int J Epidemiol 1989;
18:84e8.
[10] Lange P, Parner J, Prescott E, Vestbo J. Chronic bronchitis in
an elderly population. Age Ageing 2003;32:636e42.
[11] Pelkonen M. Smoking: relationship to chronic bronchitis,
chronic obstructive pulmonary disease and mortality. Curr
Opin Pulm Med 2008;14:105e9.
[12] Huhti E, Ikkala JA. 10-year follow-up study of respiratory
symptoms and ventilatory function in middle-aged rural pop-
ulation. Eur J Respir Dis 1980;61:33e45.
[13] Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of
chronic bronchitis and the risk of coronary disease. Lancet
1996;348:567e72.
[14] Lindstro¨m M, Kotaniemi J, Jo¨nsson E, Lundba¨ck B. Smoking,
respiratory symptoms, and diseases. A comparative study
between Northern Sweden and Northern Finland: report from
the FinEsS Study. Chest 2001;119:852e61.
[15] Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P,
Puska P. Cardiovascular risk factor factor changes in Finland,
1972e1997. Int J Epidemiol 2000;29:49e56.
[16] Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking,
smoking cessation, and lung cancer in the UK since 1950:
combination of national statistics with two case-control
studies. BMJ 2000;321:323e8.
[17] Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The
changing phases of the lung cancer epidemic from 1967 to
1999 in the 15 European Union countries. Eur J Cancer 2004;
40:96e125.
[18] Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Ma¨nnisto¨ S,
Sudvall J, Jousilahti P, Salomaa V, Valsta L, Puska P. Thirty-
five-year trends in cardiovascular risk factors in Finland. Int J
Epidemiol 2010;39(2):504e18.
[19] WHO MONICA project Principal Investigators. The World
Health Organization MONICA Project (monitoring trends and
determinants of cardiovascular disease): a major interna-
tional collaboration. J Clin Epidemiol 1988;41:105e14.
[20] Tolonen H, Kuulasmaa K, Laatikainen T, Wolf H, The European
Health Risk Monitoring Project. Recommendation for in-
dicators, international collaboration, protocol and manual of
operations for chronic disease risk factor surveys. -publica-
tions from the EHRM Project; October 2002. www, http://
www.ktl.fi/ehrm.
[21] Rose GA, Blackburn H. Cardiovascular survey methods. Geneva:
World Health Organization. Monograph Series; 1968. p. 177e8.
[22] Sunyer J, Jarvis D, Gotschi T, Garcia-Esteban R, Jacquemin B,
Aguilera I, Ackerman U, de Marco R, Forsberg B, Gislason T,
Heinrich J, Norba¨ck D, Villani S, Ku¨nzli N. Chronic bronchitis
and urban air pollution in an international study. Occup En-
viron Med 2006;63:836e43.
[23] Giskes K, Kunst AE, Benach J, Borrell C, Costa G, Dahl E,
Dalstra JA, Federico B, Helmert U, Judge K, Lahelma E,
Moussa K, Ostergren PO, Platt S, Prattala R, Rasmussen NK,
Mackenbach JP. Trends in smoking behaviour between 1985
and 2000 in nine European countries by education. J Epidemiol
Community Health 2005;59:395e401.
[24] Arnett DK, McGovern PG, Jacobs DR, Shahar E, Duval S,
Blackburn H, Luepker RV. Fifteen-year trends in cardiovascu-
lar risk factors (1980e1982 through 1995e1997). The Minne-
sota Heart Survey. Am J Epidemiol 2002;156:929e35.
[25] Jousilahti P, Helakorpi S. Prevalence of exposure to environ-
mental tobacco smoke at work and at homee 15-year trends in
Finland. Scand JWork Environ Health 2002;28(Suppl. 2):16e20.
[26] Heloma A, Helakorpi S, Honkonen J, Danielsson P, Uutela A.
Exposur to second hand smoke in Finnish workplaces and
compliance with national smoke-free workplace legislation.
Scand J Public Health 2011;39:723e9.
[27] Simoni M, Baldacci S, Puntoni R, Pistelli F, Farchi S, Lo
Presti E, Pistelli R, Corbo G, Agabiti N, Basso S, Matteeli G, Di
1640 M.K. Pelkonen et al.Pede F, Carrozzi L, Forastiere F, Viegi G. Respiratory symp-
toms/diseases and environmental tobacco smoke (ETS) in
never smoker Italian women. Thorax 2007;101:531e8.
[28] Tashkin DP, Rennard S, Taylor Hays J, Lawrence D, Marton JP,
Lee TC. Lung function and respiratory symptoms in a 1-year
randomized smoking cessation trial of varenicle in COPD pa-
tients. Respir Med 2011;105:1682e90.
[29] Heederik D, Kromhout H, Burema J, Biersteker K, Kromhout D.
Occupational exposure and 25-year incidence rate of non-
specific lung disease: the Zutphen study. Int J Epidemiol
1990;19:945e52.
[30] Kokko S. Integrated primary health care: Finnish solutions and
experiences. Int J Integr Care 2009;9:e86.
[31] Regalado J, Perez-Padilla R, Sansores R, Ramirez SI, Brauer M,
Pare´ P, Vedal S. The effect of biomass burning on respiratory
symptoms and lung function in rural Mexican women. Am J
Respir Crit Care Med 2006;174:901e5.
[32] Ro¨nmark EP, Ekerljung L, Lo¨tvall J, Tore´n K, Ro¨nmark E,
Lundba¨ck B. Large scale questionnaire survey on respiratory
health in Sweden: effects of late- and non-response. Respir
Med 2009;103:1807e15.
[33] Lundba¨ck B, Ro¨nmark E, Jo¨nsson E, Larsson K, Sandstro¨m T.
Incidence of physician-diagnosed asthma in adults e a realincidence or a result of increased awareness? Report from the
obstructive lung disease in Northern Sweden Studies. Respir
Med 2001;95:685e92.
[34] Pallasaho P, Lundba¨ck B, Meren M, Kiviloog J, Loit HM,
Larsson K, Laitinen LA. Prevalence and risk factors for asthma
and chronic bronchitis in the capitals Helsinki, Stockholm and
Tallinn. Respir Med 2002;96:759e69.
[35] de Marco R, Accordini S, Cerveri I, Corsico A, Anto JM,
Ku¨nzli N, Janson C, Sunyer J, Jarvis D, Chinn S, Vermeire P,
Svanes C, Ackermann-Liebrich U, Gislason T, Heinrich J,
Leynaert B, Neukirch F, Schouten JP, Wjst M, Burney P. Inci-
dence of chronic obstructive pulmonary disease in a cohort of
young adults according to the presence of chronic cough and
phlegm. Am J Respir Crit Care Med 2007;175:32e9.
[36] Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE,
Hersh CP, Stinson D, Silverman ER, Criner GJ. The chronic
bronchitic phenotype of COPD. An analysis of the COPDGene
study. Chest 2011;140(3):626e33.
[37] Bjerg A, Ekerljung L, Eriksson J, Olafsdottir IS, Middelveld R,
Franklin KA, Forsberg B, Larsson K, Lo¨tvall J, Toren K,
Dahlen S-E, Lundba¨ck B, Janson C. Higher risk of wheeze in
female than male smokers. Results from the Swedish GA2Len
Study. PLos One 2013;8(1):e54137.
